Three Distinct Subtypes of T2DM Identified
Based on these groupings, physicians can provide more individualized treatment
Chronic Pain Conditions Cost $32K Per Patient Annually
Outpatient visits (mean of nearly 19 visits per year per patient) primarily drive costs
Synchronized Prescription Renewal Process Saves Time
Renewing all patient's stable medications for 12 to 15 months can save time and money
Stewardship Could Improve Appropriate Medical Imaging Use
Stewardship model could guide use to improve clinical outcomes and create value at point of care
Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate
Part D Enrollment Doesn’t Improve Outcomes After AMI
Half of AMI patients enrolled in Part D by hospital discharge; outcomes no better than non-enrollees
Despite Progress, Mortality Still Risk Up in Patients With T2DM
Risks vary per age, glycemic control, and renal complications
More Prescription Opioid Addicts Are Turning to Heroin
Interviews with addicts confirm desire for cheaper, more plentiful substitute
Many Seniors May Be Overtreated for T2DM, Hypertension
Physicians may be concerned about malpractice claims or performance measure variables
Flu Vaccine Slightly Less Effective in Patients on Statins
Research suggests cholesterol-lowering meds linked to lower levels of influenza antibodies in seniors
